Cytogenetic and Molecular Response to Imatinib in High Risk (Sokal) Chronic Myeloid Leukemia (CML): Results of An European Leukemianet Prospective Study Comparing 400 Mg and 800 Mg Front-Line

Author
Bostrom, Hans
Baccarani, Michele
Castagnetti, Fausto
Simonsson, Bengt
Porkka, Kimmo
HAZNEDAROĞLU, İBRAHİM CELALETTİN
Nielsen, Johann Lanng
Hjorth-Hansen, Henrik
Weis-Bjerrum, Ole
Testoni, Nicoletta
Martinelli, Giovanni
Pane, Fabrizio
Saglio, Giuseppe
Rosti, Gianantonio
Nagler, Arnon
Palandri, Francesca
Cambrin, Giovanna Rege
Levato, Luciano
Palmieri, Fausto
Abruzzese, Elisabetta
Oezbek, Ugur
Kairisto, Veli
Metadata
Show full item record
URI
http://hdl.handle.net/20.500.12627/48523
Collections